Kestra Medical Technologies Stock Forecast
NASDAQ: KMTSHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
KMTS analyst consensus
Consensus (8 analysts)
strong_buy
Avg. price target
$30.29+17.54%
- Strong buy 2
- Buy 5
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering Kestra Medical Technologies (2026-10-07), 7 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $30.29, with a high estimate of $32.00 and a low estimate of $28.00. The average target implies upside of 17.5% from the current price of $25.77.
The spread between the highest and lowest targets is 14.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for KMTS.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 25% |
| Buy | 5 | 63% |
| Hold | 1 | 13% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $28.00 | +8.65% |
| Average target | $30.29 | +17.54% |
| High target | $32.00 | +24.18% |